Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
16.66
-0.27 (-1.59%)
Dec 27, 2024, 10:04 AM EST - Market open
ARCT Market Cap
ARCT has a market cap or net worth of $451.28 million as of December 27, 2024. Its market cap has decreased by -27.81% in one year.
Market Cap
451.28M
Enterprise Value
250.83M
1-Year Change
-27.81%
Ranking
Category
Stock Price
$16.66
Market Cap Chart
Since October 22, 2013, ARCT's market cap has increased from $222.10M to $451.28M, an increase of 103.19%. That is a compound annual growth rate of 6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 447.80M | -46.85% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 10.54% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 458.50M |
| Alpha Teknova | 458.45M |
| UroGen Pharma | 456.60M |
| Esperion Therapeutics | 453.18M |
| Emergent BioSolutions | 449.73M |
| Allogene Therapeutics | 438.21M |
| Alumis | 437.43M |
| Treace Medical Concepts | 434.21M |